Brief Report: Impaired In Vivo Neovascularization Capacity of Endothelial Progenitor Cells in Patients With Systemic Sclerosis

Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine

(2013) Paola Cipriani et al.   ANGIOGENESIS

Quantification of circulating endothelial progenitor cells in systemic sclerosis: a direct comparison of protocols

(2012) Masataka Kuwana et al.   ANNALS OF THE RHEUMATIC DISEASES

Evidence for reduced angiogenesis in bone marrow in SSc: immunohistochemistry and multiparametric computerized imaging analysis

(2012) V. Carrai et al.   RHEUMATOLOGY

Bone marrow-derived mesenchymal stem cells from early diffuse systemic sclerosis exhibit a paracrine machinery and stimulate angiogenesis in vitro

(2011) S. Guiducci et al.   ANNALS OF THE RHEUMATIC DISEASES

Insights into the pathogenesis of systemic sclerosis based on the gene expression profile of progenitor-derived endothelial cells

(2011) Jérôme Avouac et al.   ARTHRITIS AND RHEUMATISM

Endothelial progenitor cells: Quo Vadis?

(2010) Matthew R. Richardson et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

Enhanced angiogenic potency of monocytic endothelial progenitor cells in patients with systemic sclerosis

(2010) Yukie Yamaguchi et al.   ARTHRITIS RESEARCH & THERAPY

EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells

(2008) J H W Distler et al.   ANNALS OF THE RHEUMATIC DISEASES

Angiogenesis in systemic sclerosis: Impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions

(2008) J. Avouac et al.   ARTHRITIS AND RHEUMATISM